首页|HIV感染合并冠心病治疗的研究进展

HIV感染合并冠心病治疗的研究进展

扫码查看
随着抗逆转录病毒治疗变得更为普遍,获得性免疫缺陷综合征(艾滋病)患者的寿命明显延长。由于传统和非传统风险因素的影响,相较于普通人群,艾滋病患者罹患冠状动脉疾病的风险明显增高,疾病进展也更早。并且目前针对艾滋病的治疗仍存在局限性,部分药物可通过多种机制加重心血管疾病风险。近年来,中国人类免疫缺陷病毒(HIV)感染人口数量不断上升,探索HIV感染合并冠心病患者的治疗策略至关重要。因此,该文就HIV感染合并冠心病治疗方面的研究进展进行综述。
Research progress in the treatment of HIV infection complicated with coronary heart disease
With the widespread use of antiretroviral therapy,the life expectancy of patients with ac-quired immunodeficiency syndrome(AIDS)has been significantly extended.Due to both traditional and non-traditional risk factors,AIDS patients have a significantly higher risk of developing coronary artery disease and experience earlier disease progression compared to the general population.Additionally,current treatments for AIDS have limitations,and some medications can increase the risk of cardiovascular disease through various mechanisms.In recent years,the number of people infected with human immunodeficiency virus(HIV)in China has been increasing,and it is crucial to explore treatment strategies for patients with HIV infection complicated with coronary heart disease.Therefore,this article reviews the research progress in the treatment of HIV infection complicated with coronary heart disease.

Acquired immunodeficiency syndromeHuman immunodeficiency virusInfectionCoronary atherosclerotic heart diseaseTreatmentResearch progressReview

王昱媛、吴奇

展开 >

成都医学院第一附属医院心内科,四川成都 610500

成都医学院第二附属医院/核工业四一六医院心内科,四川成都 610057

获得性免疫缺陷综合征 人类免疫缺陷病毒 感染 冠状动脉粥样硬化性心脏病 治疗 研究进展 综述

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(24)